World Journal of Urology

, Volume 14, Issue 6, pp 375–379

The renal paracrine peptide system — possible urologic implications of urodilatin

  • M. Meyer
  • C. G. Stief
  • A. J. Becker
  • M. C. Truss
  • A. Taher
  • U. Jonas
  • W.-G. Forssmann
Free papers


Cardiodilatin/atrial natriuretic peptide (CDD/ANP) is a hormone system of great clinical importance. The prohormone CDD/ANP-1-126 is a peptide synthesized in the heart and cleaved during exocytosis into the circulating form CDD/ANP-99-126. Urodilatin (CDD/ANP-95-126) is a homologue natriuretic peptide that differs from CDD/ANP-99-126 by four amino acids. Whereas CDD/ANP-99-126 circulates in blood plasma and is not excreted into the urine, urodilatin is detected only in urine. Urodilatin exerts its renal effects in a paracrine fashion. After its secretion from cells in the distal tubule, it interacts with luminally located receptors in the collecting duct, resulting in increased diuresis and natriuresis. Results suggest that urodilatin plays an important role in the physiologic regulation of fluid balance and sodium homeostasis. Pharmacology studies reveal significant differences when urodilatin and CDD/ANP-99-126 are given intravenously, showing that stronger diuresis and natriuresis are induced by urodilatin as compared with those induced by CDD/ANP-99-126. Clinical studies indicate the prophylactic and therapeutic effect of urodilatin in patients suffering from acute renal failure following heart and liver transplantation. A significant reduction in requirements for hemodialysis/hemofiltration can be achieved using urodilatin. Postobstructive diuresis and natriuresis is probably due to a defective urinary concentrating mechanism and is usually resistant to treatment with antidiuretic hormone. The distal tubule and collecting duct have often been considered to be the site of altered sodium and water excretion following relief of obstruction. Since circulating CDD/ANP-99-126 levels are markedly elevated during obstruction and decrease upon relief of the obstruction, natriuretic peptides may play an important role in this clinical feature. On the basis of recent findings attributing an important role in sodium homeostasis to urodilatin in contrast to CDD/ANP-99-126, future studies have to clarify whether urodilatin, not CDD/ANP-99-126, might be responsible for the altered renal sodium excretion observed in postobstructive diuresis.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bourgoignie JJ, Hwang KH, Ipakchi E, Bricker NS (1974) The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients. J Clin Invest 53:1559–1567Google Scholar
  2. 2.
    Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML (1990) Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70:665–699Google Scholar
  3. 3.
    Brenner P, Meyer M, Reichenspurner H, Meiser B, Müller R, Mentz P, Schulz-Knappe P, Überbacher HJ, Kreuzer E, Überführ P, Guder WG, Wenzlaff H, Teschemacher H, Reichart B, Forssmann W-G (1995) Significance of prophylactic Urodilatin (INN: Ularitide) infusion for prevention of acute renal failure in patients after heart transplantation. Eur J Med Res 1:137–143Google Scholar
  4. 4.
    Cedidi C, Meyer M, Kuse ER, Schulz-Knappe P, Ringe B, Frei U, Pichlmayr R, Forssmann WG (1994) Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur J Clin Invest 24:632–639Google Scholar
  5. 5.
    Currie MG, Geller DM, Cole BR, Boylan JG, Yu-Sheng W, Holmberg SW, Needleman P (1983) Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 221:71–73Google Scholar
  6. 6.
    deBold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89–94Google Scholar
  7. 7.
    Drummer C, Fiedler F, Konig A, Gerzer R (1991) Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol 1:1109–1113Google Scholar
  8. 8.
    Drummer C, Fiedler F, Bub A, Kleefeld D, Dimitriades E, Gerzer R, Forssmann WG (1993) Development and application of a urodilatin (CDD/ANP-95–126)-specific radioimmunoassay. Pflugers Arch 423:372–377Google Scholar
  9. 9.
    Drummer C, Gerzer R, Heer M, Molz B, Bie P, Schlossberger M, Stadaeger C, Röcker L, Strollo F, Heyduck B, Bauer K, Warberg J, Baisch F, Christensen NJ, König A, Norsk P (1993) Effects of an acute saline infusion on fluid and electrolyte metabolism in humans. Am J Physiol 262:F744-F754Google Scholar
  10. 10.
    Espiner EA, Nicholls MG, Yandle TG, Crozier IG, Cuneo RC, McCormick D, Ikram H (1986) Studies on the secretion, metabolism, and action of atrial natriuretic peptide in man. J Hypertens [Suppl] 2:85–91Google Scholar
  11. 11.
    Falls WF, Stacey WK (1973) Post-obstructive diuresis. Studies in a dialysed patient with a solitary kidney. Am J Med 23:554–564Google Scholar
  12. 12.
    Figuera CD, Lewis HM, MacIver AG, Mackenzie JC, Bhoola KD (1990) Cellular localisation of atrial natriuretic factor in the human kidney. Nephrol Dial Transplant 5:25–31Google Scholar
  13. 13.
    Forssmann WG (1986) Cardiac hormones. I. Review on the morphology, biochemistry, and molecular biology of the endocrine heart. Eur J Clin Invest 16:439–451Google Scholar
  14. 14.
    Forssmann WG, Hock D, Lottspeich F, Henschen A, Kreye V, Christmann M, Reinecke M, Metz J, Carlquist M, Mutt V (1983) The right auricle of the heart is an endocrine organ. Anat Embryol 168:307–313Google Scholar
  15. 15.
    Forssmann WG, Feller SM, Meyer M, Rippegather R, Schulz-Knappe P (1989) Morphology of the myoendocrine cardiac cell and extra-auricular systems producing cardiac hormones. In: Kaufmann W, Wambach G (eds) Endocrinology of the heart. Springer, Berlin Heidelberg New York, pp 3–26Google Scholar
  16. 16.
    Forssmann WG, Nokihara K, Gagelmann M, Hock D, Feller SM, Schulz-Knappe P, Herbst F (1989) The heart is the center of a new endocrine, paracrine and neuroendocrine system. Arch Histol Cytol 52:293–315Google Scholar
  17. 17.
    Forssmann WG, Meyer M, Schulz-Knappe P (1994) Urodilatin: from cardiac hormones to clinical trials. Exp Nephrol 2:318–323Google Scholar
  18. 18.
    Fried TA, Ayon MA, McDonald G, Lau A, Inagami T, Stein JH (1987) Atrial natriuretic peptide, right atrial pressure, and sodium excretion rate in the rat. Am J Physiol 253:F969-F975Google Scholar
  19. 19.
    Gagelmann M, Hock D, Forssmann WG (1988) Urodilatin (CDD/ANP-95–126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99–126). FEBS Lett 233:249–254Google Scholar
  20. 20.
    Goetz KL (1993) Is urodilatin (rather than atriopeptin) the primary natriuretic peptide of the ANP family? J Cardiovasc Pharmacol 22 [Suppl 2]:S84-S85Google Scholar
  21. 21.
    Goetz K, Drummer C, Zhu JL, Leadley R, Fiedler F, Gerzer R (1990) Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J Am Soc Nephrol 1:867–874Google Scholar
  22. 22.
    Grammer RT, Fukumi H, Inagami T, Misono KS (1983) Rat atrial natriuretic factor: purification and vasorelaxant activity. Biochem Biophys Res Commun 116:696–703Google Scholar
  23. 23.
    Gulmi FA, Mooppan UM, Chou S, Kim H (1989) Atrial natriuretic peptide in patients with obstructive uropathy. J Urol 142:268–272Google Scholar
  24. 24.
    Gutkowska J, Schiffrin EL, Cantin M, Genest J (1986) Effect of dietary sodium on plasma concentration of immunoreactive atrial natriuretic factor in normal humans. Clin Invest Med 9:222–224Google Scholar
  25. 25.
    Heer M, Drummer C, Baisch F, Gerzer R (1993) Long-term elevations of dietary sodium produce parallel increases in the renal excretion of urodilatin and sodium. Pflugers Arch 425:390–394Google Scholar
  26. 26.
    Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T (1989) Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 83:623–628Google Scholar
  27. 27.
    Hummel M, Kuhn M, Bub A, Bittner H, Kleefeld D, Marxen P, Schneider B, Hetzer R, Forssmann WG (1992) Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients. Clin Invest 70:674–682Google Scholar
  28. 28.
    Jones DA, George NJ, O'Reilly PH (1987) Postobstructive renal function. Semin Urol 5:176–190Google Scholar
  29. 29.
    Jones DA, George NJ, O'Reilly PH, Barnard RJ (1987) Reversible hypertension associated with unrecognised high pressure chronic retention of urine [published erratum in Lancet I: 1220]. Lancet I:1052–1054Google Scholar
  30. 30.
    Kleinert HD, Maack T, Atlas SA, Januszewicz A, Sealey JE, Laragh JH (1984) Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. Hypertension 6:I143-I147Google Scholar
  31. 31.
    Koller KJ, Goeddel GV (1992) Molecular biology of the natriuretic peptides and their receptors. Circulation 86:1081–1084Google Scholar
  32. 32.
    Kuse E-R, Meyer M, Constantin R, Oldhafer K, Schlitt H-J, Schulz-Knappe P, Überbacher H-J, Pichlmayr R, Forssmann W-G (1996) Urodilatin (INN: Ularitide) — a novel peptide for the treatment of postoperative acute renal failure following liver transplantation. Anaesthesist 45:351–358Google Scholar
  33. 33.
    Laws J, Kropp S, Meyer M, Forssmann W-G, Burdach S (1995) Treatment of acute renal failure with Urodilatin after unrelated bone marrow transplantation in an 18-month-old boy. Bone Marrow Transplant 16:307–310Google Scholar
  34. 34.
    Maack T (1992) Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11–27Google Scholar
  35. 35.
    Maher JF, Schreiner GE, Waters TJ (1963) Osmotic diuresis due to retained urea after release of obstructive uropathy. N Engl J Med 268:1099–1112Google Scholar
  36. 36.
    Mason J (1990) The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 4:686–704Google Scholar
  37. 37.
    Meyer M, Richter R, Brunkhorst R, Wrenger E, Schulz-Knappe P, Kist A, Mentz P, Brabant G, Koch KM, Rechkemmer G, Forssmann WG (1996) Urodilatin is involved in sodium homeostasis and exerts sodium-state dependent natriuretic and diuretic effects. Am J Physiol (in press)Google Scholar
  38. 38.
    Perrella MA, Margulies KB, Chi-Ming W, Aarhus LL, Heublein DM, Burnett JC (1991) Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest 87:1649–1655Google Scholar
  39. 39.
    Riegger GA, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K (1988) Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 77:398–406Google Scholar
  40. 40.
    Riegger GAJ, Elsner D, Forssmann WG, Kromer EP (1990) Effects of ANP-(95–126) in dogs before and after induction of heart failure. Am J Physiol 259:H1643-H1648Google Scholar
  41. 41.
    Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG (1990) Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 259:F832-F838Google Scholar
  42. 42.
    Schramm L, Heidbreder E, Schaar J, Lopau K, Zimmermann J, Götz R, Ling H, Heidland A (1994) Toxic acute renal failure in the rat: effects of Diltiazem and Urodilatin on renal function. Nephron 68:454–461Google Scholar
  43. 43.
    Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of “urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752–759Google Scholar
  44. 44.
    Schulz-Knappe P, Honrath U, Forssmann WG, Sonnenberg H (1990) Endogenous natriuretic peptides: effect on collecting duct function in rat kidney. Am J Physiol 259:F415-F418Google Scholar
  45. 45.
    Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 332:78–81Google Scholar
  46. 46.
    Sudoh T, Minamino N, Kangawa K, Matsuo H (1990) C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168:863–870Google Scholar
  47. 47.
    Vaughan ED Jr, Gillenwater JY (1973) Diagnosis, characterization and management of post-obstructive diuresis. J Urol 109:286–292Google Scholar
  48. 48.
    Wiebe K, Meyer M, Wahlers T, Michels P, Zenker D, Schulze F-P, Dalichau H, Mohr FW, Forssmann W-G (1996) Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide). Eur J Med Res 1:259–265Google Scholar
  49. 49.
    Wilson DR (1980) Pathophysiology of obstructive nephropathy. Kidney Int 18:281–292Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • M. Meyer
    • 1
  • C. G. Stief
    • 2
  • A. J. Becker
    • 2
  • M. C. Truss
    • 2
  • A. Taher
    • 3
  • U. Jonas
    • 2
  • W.-G. Forssmann
    • 1
  1. 1.Lower Saxony Institute for Peptide ResearchHannoverGermany
  2. 2.Department of UrologyHannover Medical SchoolHannoverGermany
  3. 3.Department of UrologyUniversity of JakartaJakartaIndonesia

Personalised recommendations